Tyr7

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Tyr7 - P311 iso2 (human)

Site Information
_MKGVWNySALSRRE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 22912404

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 1 )

References
1	Zhou J (2011) CST Curation Set: 11707; Year: 2011; Biosample/Treatment: cell line, HeLa/UV; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]Q Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) ATM/ATR Substrate (S/TQG) (P-S/T2-100) Rabbit mAb Cat#: 6966, PTMScan(R) Phospho-ATM/ATR Substrate Motif (S/TQG) Immunoaffinity Beads Cat#: 6969 Curated Info

References

1

Zhou J (2011) CST Curation Set: 11707; Year: 2011; Biosample/Treatment: cell line, HeLa/UV; Disease: cervical adenocarcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]Q Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) ATM/ATR Substrate (S*/T*QG) (P-S/T2-100) Rabbit mAb Cat#: 6966, PTMScan(R) Phospho-ATM/ATR Substrate Motif (S*/T*QG) Immunoaffinity Beads Cat#: 6969
Curated Info

PhosphoSitePlus^® is a registered trademark of Cell Signaling Technology.
Use of PSP data is subject to a formal license agreement. Learn more